Kenvue (KUVE) has named Kirk Perry, a current director, as its interim CEO, effective immediately. Concurrently, Thibaut Mongon has left the company and resigned from the Kenvue board. Perry, who joined Kenvue’s board of directors in December 2024,

Perry is a current Kenvue director and seasoned consumer products and brand strategist with more than 30 years of experience. Of his appointment, Larry Merlo, Kenvue’s chair of

Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic review of the company.

Kenvue (KVUE) said on Monday that CEO Thibaut Mongon has left the company and stepped down from its board, with Kirk Perry succeeding him as the interim chief executive officer, effective immediately.

Kenvue chief executive officer, Thibaut Mongon, has stepped down from the role and the company's board amid an ongoing organisational review.

Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.

American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim CEO on Monday.

Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what some investors expect will be the groundwork for an eventual sale of the entire company or pieces of it.

Kenvue stock yo-yoes Monday after the company — known for brands like Tylenol — announced a new CEO and strategic review.

Kenvue shares (KVUE) are in focus Monday after the consumer health firm ousted its CEO, Thibaut Mongon, and announced a strategic review aimed at optimizing the portfolio. Kirk Perry will be the interim chief executive as the company searches for a permanent replacement,